Exploring the medicinal properties of Galbulimima bark for pain relief and addiction treatment
Official title: Deconvolution of Galbulimima bark pharmacology through chemical synthesis and target assignment
Funded at Scripps Research Institute, the · NIH-11042756 · Data updated 2026-11-12
This study is looking at natural compounds from the Galbulimima bark, which might help with pain relief and addiction, to see how they work and if they can lead to new treatment options for people who need them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | June 8, 2023 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $663,419 |
| NIH project number | 5R01AT012075-03 |
| Project ID | NIH-11042756 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals suffering from chronic pain conditions or those struggling with addiction.
✕Less likely to help
Patients with acute pain or those not affected by addiction may not receive benefit from this research.
What this research studies
This research investigates the pharmacological properties of alkaloids derived from the Galbulimima bark, which is traditionally used in Papua New Guinea. The study aims to identify the specific biological targets of these alkaloids and their potential effects on pain sensation and addiction. By employing advanced chemical synthesis techniques, the researchers are developing new methods to produce these compounds and assess their pharmacological effects in laboratory settings. Patients may benefit from insights into new pain relief options and treatments for addictive disorders.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for managing pain and treating addiction.
How similar studies have gone: While the specific approach of this research is novel, previous studies have shown promise in exploring the pharmacological potential of plant-derived compounds.
Where this research is happening
-
Scripps Research Institute, the
La Jolla, United States Active
Researchers
- Principal investigator: Shenvi, Ryan Ashok — Scripps Research Institute, the
- Study coordinator: Shenvi, Ryan Ashok
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.